Evidence map›Paper›PMID 28702462›Full record

ArticleJournal of immunology research2017

Adoptive Cell Therapy of Induced Regulatory T Cells Expanded by Tolerogenic Dendritic Cells on Murine Autoimmune Arthritis.

Jie Yang, Lidong Liu, Yiming Yang, Ning Kong, Xueyu Jiang, Juan Sun, Rufeng Xie

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of immunology research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Cell-based therapies for rheumatoid arthritis: opportunities and challenges.Therapeutic advances in musculoskeletal disease · 2022
    Review
  4. Review
  5. Tregs in Autoimmune Uveitis.Advances in experimental medicine and biology · 2021
    Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Jie YangBlood Engineering Laboratory, Shanghai Blood Center, Shanghai 200051, China.ORCID 0000-0003-3031-0504
Lidong LiuBlood Engineering Laboratory, Shanghai Blood Center, Shanghai 200051, China.
Yiming YangBlood Engineering Laboratory, Shanghai Blood Center, Shanghai 200051, China.ORCID 0000-0001-9189-7121
Ning KongDivision of Rheumatology, Huashan Hospital, Fudan University, Shanghai 200040, China.
Xueyu JiangBlood Engineering Laboratory, Shanghai Blood Center, Shanghai 200051, China.
Juan SunBlood Engineering Laboratory, Shanghai Blood Center, Shanghai 200051, China.
Rufeng XieBlood Engineering Laboratory, Shanghai Blood Center, Shanghai 200051, China.
Shanghai Blood Center · CNFudan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTolerogenic dendritic cells (tDCs) can expand TGF-

methodsAfter induction by TGF-

resultsCompared with iTregs, iTreg

conclusionThis study highlights the potential therapeutic utility of iTreg

Indexed as

Immune ToleranceImmunotherapy, AdoptiveAnimalsArthritis, ExperimentalAutoimmune DiseasesCell DifferentiationCell ProliferationCytokinesDendritic CellsForkhead Transcription FactorsInterleukin-17Interleukin-6Lymphocyte ActivationMiceMice, Inbred DBATh17 CellsCytokinesForkhead Transcription FactorsFoxp3 protein, mouseInterleukin-17Interleukin-6Transforming Growth Factor betaTumor Necrosis Factor-alpha

Identifiers

PMID28702462
PMCPMC5494067
OpenAlexW2625472356

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.